Checked, not settled
Checks out so far.
“In the PATHFINDER 2 study, among 32,007 performance-analyzable participants, the multi-cancer early-detection test had a 0.54% cancer detection rate, 60.3% positive predictive value, 99.2% negative predictive value, and 99.64% specificity.”
3 of 4 review checks done · 1 counted · 2 by the author only
Supported · 0.9561 under ledger-default@0.3.0 at snapshot 27745 · review checks 1 of 4 · provisional until audited. The number is model-conditional, not a share of truth.
Share:
Checked in Galedra: score 0.96, strongly supported · not yet reviewed by anyone else
“In the PATHFINDER 2 study, among 32,007 performance-analyzable participants, the multi-cancer early-detection test had a 0.54% cancer detection rate, 60.3% positive predictive value, 99.2% negative…”
https://galedra.org/claims/2bd30a15-4037-814d-9fff-a1134fbcef11/card
Or just the link: https://galedra.org/claims/2bd30a15-4037-814d-9fff-a1134fbcef11/card
See the evidence · 
Galedra